Log in
Enquire now
‌

US Patent 7816334 Materials and methods relating to immune responses to fusion proteins

Patent 7816334 was granted and assigned to Cancer Research Technology Limited on October, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
‌
Cancer Research Technology Limited
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
78163340
Patent Inventor Names
Freda Stevenson0
Jason Rice0
Date of Patent
October 19, 2010
0
Patent Application Number
102576570
Date Filed
April 17, 2001
0
Patent Citations Received
‌
US Patent 12060437 Methods and compositions for antibody to high affinity receptor for IgE
0
Patent Primary Examiner
Quang Nguyen
Quang Nguyen
0
Patent abstract

The invention provides nucleic acid construct and nucleic acid expression vectors directing the expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin. The invention provides nucleic acid (DNA) vaccines for use in inducing an immune response against a disease. There is also provided methods of producing nucleic acid constructs and vectors for use as nucleic acid (DNA) vaccines.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7816334 Materials and methods relating to immune responses to fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us